Filing Details

Accession Number:
0001552781-16-001976
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-05 16:49:32
Reporting Period:
2016-10-03
Filing Date:
2016-10-05
Accepted Time:
2016-10-05 16:49:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587150 Lynn Cilinski 9704 Medical Center Drive
Rockville MD 20850
Vp, Controller And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-10-03 6,231 $0.94 8,154 No 4 M Direct
Common Stock Disposition 2016-10-03 6,231 $29.28 1,923 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-10-03 2,237 $0.00 2,237 $0.94
Common Stock Employee Stock Option (right to buy) Disposition 2016-10-03 3,994 $0.00 3,994 $0.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-07-11 2019-01-10 No 4 M Direct
0 2010-07-10 2020-01-09 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $28.755 to $29.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.